Cabaletta Bio, Inc.
NASDAQ:CABA
1.19 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 1.426 | 3.684 | 0.733 | 0.354 | 0.104 | 0 | 0 |
| Gross Profit
| 0 | -1.426 | -3.684 | -0.733 | -0.354 | -0.104 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 97.203 | 55.424 | 39.3 | 32.494 | 21.376 | 11.671 | 4.467 | 0 |
| General & Administrative Expenses
| 27.938 | 19.236 | 14.839 | 13.819 | 12.457 | 7.012 | 1.726 | 0.333 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.083 |
| SG&A
| 27.938 | 19.236 | 14.839 | 13.819 | 12.457 | 7.012 | 1.726 | 0.25 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | -6.244 | 0 |
| Operating Expenses
| 125.141 | 74.66 | 54.139 | 46.313 | 33.833 | 18.683 | 6.193 | 0.25 |
| Operating Income
| -125.141 | -74.66 | -54.139 | -46.313 | -33.833 | -18.683 | -6.193 | -0.25 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 9.277 | 6.985 | 1.164 | 0.024 | 0.494 | 1.74 | -6.009 | 0.083 |
| Income Before Tax
| -115.864 | -67.675 | -52.975 | -46.289 | -33.339 | -16.943 | -12.202 | -0.25 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -1.164 | -0.757 | -0.848 | -1.844 | -0.235 | -0.333 |
| Net Income
| -115.864 | -67.675 | -51.811 | -45.532 | -32.491 | -15.099 | -12.202 | -0.25 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.37 | -1.65 | -1.77 | -1.77 | -1.4 | -0.63 | -0.84 | -0.01 |
| EPS Diluted
| -2.34 | -1.65 | -1.77 | -1.77 | -1.4 | -0.63 | -0.84 | -0.01 |
| EBITDA
| -125.141 | -73.234 | -52.961 | -45.58 | -33.479 | -18.683 | -6.009 | 0.083 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |